Skip to main content

Table 1 Number of animals ( n ), weight at time of PET, injected doses (average ± standard deviation) of ( R )-[ 11 C]verapamil for baseline and post-inhibition scans in naïve and 48-h post SE rats and different treatments with 3 or 15 mg/kg of tariquidar

From: Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[11C]verapamil positron emission tomography

 

Naïve and 3 mg/kg tariquidar treated

Naïve and 15 mg/kg tariquidar treated

48-h post SE and 3 mg/kg tariquidar treated

48-h post SE and 15 mg/kg tariquidar treated

All groups

N

7

4

5

5

21

Body weight (g)

260 ± 5

307 ± 18

234 ± 14

247 ± 16

260 ± 28

Baseline (R)-[11C]verapamil (MBq)

97 ± 27

88 ± 17

84 ± 20

94 ± 25

91 ± 22

I.V. injection time (sec)

18 ± 7

39 ± 10

19 ± 2

25 ± 11

24 ± 11

Post-inhibition (R)-[11C]verapamil (MBq)

93 ± 27

101 ± 28

91 ± 9

92 ± 16

94 ± 21

I.V. injection time (sec)

18 ± 6

36 ± 5

16 ± 2

32 ± 18

24 ± 13